Vaccine reduces child cases of bacterial pneumonia: Study
August 28th, 2010 - 3:06 pm ICT by ANIWashington, August 28 (ANI): A new study has shown that the number of children admitted to English hospitals with bacterial pneumonia decreased by a fifth in the 2 years following the introduction of a vaccine to combat the disease.
Bacterial pneumonia is a serious illness caused by Streptococcus pneumoniae bacteria that mostly affects babies, young children and elderly people. In Europe, around one in ten deaths in the under-fives is caused by the disease.
Bacterial pneumonia usually develops as a complication following a respiratory tract infection such as influenza. Symptoms include difficulty breathing, wheezing, fever and loss of appetite.
In September 2006, a vaccine known as PCV7 was introduced into the childhood primary immunisation programme across the UK, to protect against seven different strains of Streptococcus pneumoniae bacteria.
Today’s study, led by researchers from Imperial College London, shows that in the first two years following the introduction of this vaccine, hospital admissions for bacterial pneumonia decreased by 19 per cent amongst children aged under 15 years. Admissions for empyema, a rare and serious complication of bacterial pneumonia, decreased by 22 per cent.
The pneumococcal vaccine is administered at two, three and 13 months of age. When it was first introduced there was a catch-up campaign for children up to two years. Take-up of the vaccine over the study period was high. It was administered to an average of 84 per cent of eligible children in England in the first year following its introduction and 91 per cent the following year.
The study showed that the number of older children admitted with bacterial pneumonia decreased, as well as the number of younger children, following introduction of the vaccine. This result suggests that vaccinating young children against bacterial pneumonia also provides protection for older, non-vaccinated children, providing ‘herd immunity’ by slowing the spread of disease.
The PCV7 vaccine has now been replaced with a newer pneumococcal vaccine called PCV13, which works in the same way as PCV7 but protects against more strains of Streptococcus pneumoniae bacteria. There are around 90 strains of this bacteria and around a quarter of cases are caused by strains not covered by PCV13.
The study has been published in the journal Thorax. (ANI)
- Vaccine made with synthetic gene shows promise against pneumonia - Feb 22, 2011
- 'Watchful waiting' appropriate treatment for many kids with ear infections - Dec 18, 2010
- Viral infection likely to encourage pneumonia spread: Study - Apr 11, 2011
- Pneumonia vaccine offers protection to HIV patients - Mar 04, 2010
- Vaccine to tackle meningitis 'just a year away' - Dec 24, 2010
- New breakthrough paves way for vaccines against pneumonia, meningitis - Nov 12, 2010
- Paediatric vaccine found effective in preventing pneumococcal meningitis - Jan 15, 2009
- Soon, nasal spray vaccines to curb flu - Apr 12, 2011
- Vaccine for deadly meningitis strain in offing - Dec 26, 2010
- Second-hand smoke ups invasive meningococcal disease risk in kids - Dec 08, 2010
- Anthrax shot protects simians from lethal infection - Jan 13, 2012
- New WHO data sheds light on two leading causes of pneumonia - Sep 12, 2009
- Dubai hosts health congress - Mar 25, 2010
- FACTSHEETS - Smallpox: in detail - Mar 25, 2010
- Nasal spray vaccine for meningitis on the anvil - Jul 27, 2010
Tags: babies, bacterial pneumonia, deaths, difficulty breathing, eligible children, fever, herd immunity, hospital admissions, imperial college london, influenza, influenza symptoms, loss of appetite, pneumococcal vaccine, pneumonia, respiratory tract infection, spr, strains, streptococcus pneumoniae bacteria, study period, vaccinated children